<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02323048</url>
  </required_header>
  <id_info>
    <org_study_id>12-2047</org_study_id>
    <nct_id>NCT02323048</nct_id>
  </id_info>
  <brief_title>Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans</brief_title>
  <acronym>CAM</acronym>
  <official_title>Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans: Self-report, Behavioral, and Psychophysiological Measures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to extend our investigations of drug-associated conditioning with
      healthy volunteers. The investigators have recently completed a pilot study demonstrating
      that subjects show an increase in self-reported preference for a visual stimulus paired with
      stimulant drug administration. Furthermore, our pilot data suggest that methamphetamine acts
      synergistically with rewards in the environment, such that this conditioning effect is
      facilitated by experiencing the drug in the presence of rewarding, or positive events, such
      as earning money. The investigators now aim to extend these findings by assessing not only
      self-reported preference, but also attentional and psychophysiological (electromyogram; EMG)
      responses to the drug-associated stimuli.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will consist of an orientation session following by 6 experimental study sessions.
      The first experimental session will consist of a &quot;Pre-test&quot;, where baseline data regarding
      attentional, psychophysiological, and self-reported responses tovarious stimuli will be
      collected. The following 4 sessions will consist of a drug (sedative or stimulant) or
      placebo. During these sessions, subjects will play simple computer games, as well as complete
      questionnaires regarding mood and potential subjective drug effects. The subjects will then
      complete a &quot;Test&quot; session, where attentional, psychophysiological, and self-reported
      responses to the stimuli will be assessed, as in the first experimental session.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Effects as Assessed by Score on &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot; Subscales of the Drug Effects Questionnaire</measure>
    <time_frame>End of study (time 0 and approximately 4 weeks later)</time_frame>
    <description>The Drug Effects Questionnaire (DEQ) is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot;. The &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot; subscales are reported. All subscales are scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome.</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Substance Abuse</condition>
  <arm_group>
    <arm_group_label>Paired, high reward</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will be administered methamphetamine (20mg) and placebo. All subjects received methamphetamine (20 mg) on two conditioning sessions and placebo on the other two sessions, administered under double-blind conditions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paired, low reward</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will be administered methamphetamine (20mg) and placebo. All subjects received methamphetamine (20 mg) on two conditioning sessions and placebo on the other two sessions, administered under double-blind conditions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paired no reward</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will be administered methamphetamine (20mg) and placebo. All subjects received methamphetamine (20 mg) on two conditioning sessions and placebo on the other two sessions, administered under double-blind conditions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unpaired, high reward</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will be administered methamphetamine (20mg) and placebo. All subjects received methamphetamine (20 mg) on two conditioning sessions and placebo on the other two sessions, administered under double-blind conditions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unpaired, low reward</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will be administered methamphetamine (20mg) and placebo. All subjects received methamphetamine (20 mg) on two conditioning sessions and placebo on the other two sessions, administered under double-blind conditions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methamphetamine</intervention_name>
    <description>: Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.</description>
    <arm_group_label>Paired no reward</arm_group_label>
    <arm_group_label>Paired, high reward</arm_group_label>
    <arm_group_label>Paired, low reward</arm_group_label>
    <arm_group_label>Unpaired, high reward</arm_group_label>
    <arm_group_label>Unpaired, low reward</arm_group_label>
    <other_name>desoxyn</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Placebo (sugar pill)</description>
    <arm_group_label>Paired no reward</arm_group_label>
    <arm_group_label>Paired, high reward</arm_group_label>
    <arm_group_label>Paired, low reward</arm_group_label>
    <arm_group_label>Unpaired, high reward</arm_group_label>
    <arm_group_label>Unpaired, low reward</arm_group_label>
    <other_name>dextrose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI of 19-26kg/m, high school education,

          -  fluency in English,

          -  resting blood pressure less than140/90mmHg and consumption of less than 4 standard
             alcohol or caffeinated drinks per day.

        Exclusion Criteria:

          -  current substance abuse or lifetime substance dependence,

          -  regular medication,

          -  history of cardiovascular illness,

          -  current major Axis I DSM-IV disorder (APA, 2004),

          -  mood disorder or psychotic symptoms within the past year.

          -  Shift workers and pregnant or nursing mothers will also be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leah Mayo</last_name>
    <role>Study Director</role>
    <affiliation>Graduate Student</affiliation>
  </overall_official>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>December 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <results_first_submitted>December 5, 2016</results_first_submitted>
  <results_first_submitted_qc>June 29, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 26, 2018</results_first_posted>
  <last_update_submitted>June 29, 2018</last_update_submitted>
  <last_update_submitted_qc>June 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methamphetamine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy volunteers aged 18–35 were recruited through posters, online and newspaper advertisement, and word-of mouth referrals throughout the community.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Paired, High Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo. methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="P2">
          <title>Paired, Low Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo. methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="P3">
          <title>Paired, no Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo. methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="P4">
          <title>Unpaired, High Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo. methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="P5">
          <title>Unpaired, Low Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo. methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="7"/>
                <participants group_id="P5" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="7"/>
                <participants group_id="P5" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Healthy volunteers aged 18-35 with BMI between 19 and 26kg/m2, at least high school completed educated., resting bp less than 140/90, current alcohol consumption less than 4 drinks per day, less than 4 caffenated beverages per day. No major DSM IV disorder, no current psychoactive medication, no pregnancy</population>
      <group_list>
        <group group_id="B1">
          <title>Paired, High Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="B2">
          <title>Paired, Low Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="B3">
          <title>Paired, no Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="B4">
          <title>Unpaired, High Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="B5">
          <title>Unpaired, Low Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="23"/>
            <count group_id="B4" value="7"/>
            <count group_id="B5" value="9"/>
            <count group_id="B6" value="87"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="87"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.8" spread="5.0"/>
                    <measurement group_id="B2" value="23.9" spread="3.3"/>
                    <measurement group_id="B3" value="22.8" spread="2.3"/>
                    <measurement group_id="B4" value="23.3" spread="3.0"/>
                    <measurement group_id="B5" value="24.2" spread="3.7"/>
                    <measurement group_id="B6" value="23.8" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subjective Effects as Assessed by Score on &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot; Subscales of the Drug Effects Questionnaire</title>
        <description>The Drug Effects Questionnaire (DEQ) is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot;. The &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot; subscales are reported. All subscales are scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome.</description>
        <time_frame>End of study (time 0 and approximately 4 weeks later)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Paired, High Reward (Methamphetamine Sessions)</title>
            <description>All subjects received methamphetamine (20 mg) on two conditioning sessions</description>
          </group>
          <group group_id="O2">
            <title>Paired, Low Reward (Methamphetamine Sessions)</title>
            <description>All subjects received methamphetamine (20 mg) on two conditioning sessions</description>
          </group>
          <group group_id="O3">
            <title>Paired no Reward (Methamphetamine Sessions)</title>
            <description>All subjects received methamphetamine (20 mg) on two conditioning sessions</description>
          </group>
          <group group_id="O4">
            <title>Unpaired, High Reward (Methamphetamine Sessions)</title>
            <description>All subjects received methamphetamine (20 mg) on two conditioning sessions</description>
          </group>
          <group group_id="O5">
            <title>Unpaired, Low Reward (Methamphetamine Sessions)</title>
            <description>All subjects received methamphetamine (20 mg) on two conditioning sessions</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Effects as Assessed by Score on &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot; Subscales of the Drug Effects Questionnaire</title>
          <description>The Drug Effects Questionnaire (DEQ) is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot;. The &quot;Feel Drug&quot;, &quot;Feel High&quot;, &quot;Like Drug&quot;, and &quot;Want More&quot; subscales are reported. All subscales are scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="7"/>
                <count group_id="O5" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Feel Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.39" spread="3.29"/>
                    <measurement group_id="O2" value="45.25" spread="3.0"/>
                    <measurement group_id="O3" value="41.22" spread="2.5"/>
                    <measurement group_id="O4" value="48.55" spread="2.6"/>
                    <measurement group_id="O5" value="42.22" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Like Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.85" spread="3.32"/>
                    <measurement group_id="O2" value="64.25" spread="3.10"/>
                    <measurement group_id="O3" value="60.55" spread="3.0"/>
                    <measurement group_id="O4" value="61.55" spread="3.5"/>
                    <measurement group_id="O5" value="60.2" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Feel High</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.04" spread="3.79"/>
                    <measurement group_id="O2" value="41.04" spread="3.55"/>
                    <measurement group_id="O3" value="38.88" spread="3.45"/>
                    <measurement group_id="O4" value="39.55" spread="3.45"/>
                    <measurement group_id="O5" value="38.0" spread="3.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Want More</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.11" spread="3.98"/>
                    <measurement group_id="O2" value="62.44" spread="3.55"/>
                    <measurement group_id="O3" value="61.55" spread="3.44"/>
                    <measurement group_id="O4" value="60.55" spread="3.42"/>
                    <measurement group_id="O5" value="59.5" spread="3.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Paired, No Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="E2">
          <title>Paired, Low Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="E3">
          <title>Paired, High Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="E4">
          <title>Unpaired, Low Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
        <group group_id="E5">
          <title>Unpaired, High Reward</title>
          <description>All participants will be administered methamphetamine (20mg) and placebo.
methamphetamine: : Twenty milligrams of MA (Desoxyn; Lundbeck Inc) tablets will be crushed and placed in 10 ml of Ora-Sweet syrup. Placebo drinks will consist of 10 ml of Ora-Sweet alone.
placebo: Placebo (sugar pill)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Harriet de Wit</name_or_title>
      <organization>University of Chicago</organization>
      <phone>773-702-3560</phone>
      <email>dewitlab@yoda.bsd.uchicago.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

